Avricore Health Inc. (AVCRF)
OTHER OTC:AVCRF
Want to see AVCRF full AI Analyst Report?
Total Valuation
Avricore Health has a market cap or net worth of $4.68M. The enterprise value is $6.56M.
Market Cap$4.68M
Enterprise Value$6.56M
Share Statistics
Avricore Health has 101,289,665 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding101,289,665
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Avricore Health’s return on equity (ROE) is -4.77 and return on invested capital (ROIC) is -351.04%.
Return on Equity (ROE)-4.77
Return on Assets (ROA)-3.30
Return on Invested Capital (ROIC)-351.04%
Return on Capital Employed (ROCE)-3.51
Revenue Per Employee20.53K
Profits Per Employee-71.49K
Employee Count26
Asset Turnover0.95
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Avricore Health is ―. Avricore Health’s PEG ratio is -0.02.
PE Ratio―
PS Ratio9.49
PB Ratio13.00
Price to Fair Value13.00
Price to FCF-5.77
Price to Operating Cash Flow-48.33
PEG Ratio-0.02
Income Statement
In the last 12 months, Avricore Health had revenue of 533.88K and earned -1.86M in profits. Earnings per share was -0.02.
Revenue533.88K
Gross Profit236.33K
Operating Income-1.37M
Pretax Income-1.86M
Net Income-1.86M
EBITDA-1.23M
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -146.71K and capital expenditures -116.33K, giving a free cash flow of -263.03K billion.
Operating Cash Flow-146.71K
Free Cash Flow-263.03K
Free Cash Flow per Share>-0.01
Dividends & Yields
Avricore Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.85
52-Week Price Change-17.39%
50-Day Moving Average0.05
200-Day Moving Average0.05
Relative Strength Index (RSI)52.91
Average Volume (3m)60.67K
Important Dates
Avricore Health upcoming earnings date is May 28, 2026, TBA (Confirmed).
Last Earnings DateMay 1, 2026
Next Earnings DateMay 28, 2026
Ex-Dividend Date―
Financial Position
Avricore Health as a current ratio of 2.11, with Debt / Equity ratio of 0.00%
Current Ratio2.11
Quick Ratio2.11
Debt to Market Cap0.00
Net Debt to EBITDA0.19
Interest Coverage Ratio-151.48
Taxes
In the past 12 months, Avricore Health has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Avricore Health EV to EBITDA ratio is -3.94, with an EV/FCF ratio of -5.51.
EV to Sales9.06
EV to EBITDA-3.94
EV to Free Cash Flow-5.51
EV to Operating Cash Flow-6.12
Balance Sheet
Avricore Health has $541.75K in cash and marketable securities with $0.00 in debt, giving a net cash position of $541.75K billion.
Cash & Marketable Securities$541.75K
Total Debt$0.00
Net Cash$541.75K
Net Cash Per Share<$0.01
Tangible Book Value Per Share<$0.01
Margins
Gross margin is 43.41%, with operating margin of -256.15%, and net profit margin of -348.16%.
Gross Margin43.41%
Operating Margin-256.15%
Pretax Margin-348.16%
Net Profit Margin-348.16%
EBITDA Margin-230.00%
EBIT Margin-256.15%
Analyst Forecast
The average price target for Avricore Health is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-89.27%
EPS Growth Forecast-180.85%